Search results

Found 398 pages for ""
AUTHOR: George Underwood

Results per page

10 20 50 100

Sort by

Relevance Date

4 Jan 2016:

Shire and Baxalta near deal

Shire is reportedly in advanced talks to acquire Baxter's biopharma spin-off Baxalta and may announce a deal this week. - News - PharmaTimes

by George Underwood

https://www.pharmatimes.com/news/shire_and_baxalta_near_deal_1020698

6 Oct 2017:

Bayer halts Xarelto trial

Trial was evaluating the drug in patients with embolic stroke of undetermined source (ESUS). - News - PharmaTimes

by George Underwood

https://www.pharmatimes.com/news/bayer_halts_xarelto_trial_1207036

24 Oct 2018:

Medidata teams with Pharm-Olam

CRO hopes partnership will accelerate drugs' time to market - News - PharmaTimes

by George Underwood

https://www.pharmatimes.com/news/medidata_teams_with_pharm-olam_1256852

26 Sep 2017:

EC approves Janssen’s Symtuza

Drug is only darunavir-based STR indicated for HIV-1 infection in adults and adolescents - News - PharmaTimes

by George Underwood

https://www.pharmatimes.com/news/ec_approves_janssens_symtuza_1206421

3 Oct 2017:

'Universal' flu vaccine to be tested

Vaccine uses T-cells to potentially attack multiple strains of the virus - News - PharmaTimes

by George Underwood

https://www.pharmatimes.com/news/universal_flu_vaccine_to_be_tested_1206771

24 May 2016:

Lansons recruits Kate Aldous

Appointment boosts healthcare offering - Appointments - PharmaTimes

by George Underwood

https://www.pharmatimes.com/appointments/lansons_recruits_kate_aldous_1029021

2 Jun 2016:

New approval for Novartis' Afinitor

Novartis' Afinitor (everolimus) has received a boost in the face of growing competition, with European Commission approval for the treatment of unresectable or metastatic, well-differentiated nonfunctional neuroendocrine tumours (NET) of

by George Underwood

https://www.pharmatimes.com/news/new_approval_for_novartis_afinitor_1033230

29 May 2018:

Janssen terminates Darzalex/Tecentriq combo trial

Drug fails to show any benefit over Tecentriq alone in lung cancer. - News - PharmaTimes

by George Underwood

https://www.pharmatimes.com/news/janssen_terminates_darzalextecentriq_combo_trial_1237340

12 Sep 2017:

Humira gets EC approval for anterior uveitis

Humira is now the only EU biologic treatment option for children with the disease - News - PharmaTimes

by George Underwood

https://www.pharmatimes.com/news/humira_gets_ec_approval_for_anterior_uveitis_1205082

20 Jul 2015:

Demand for OTC drugs rises

Demand for over-the-counter (OTC) medicines in the UK has grown in the last year, according to a new report. - News - PharmaTimes

by George Underwood

https://www.pharmatimes.com/news/demand_for_otc_drugs_rises_971669